Biocryst Pharmaceuticals (BCRX) to Present at Two Upcoming Investor Conferences
5/9/2013 8:20:15 AM
More...
|
Biocryst Pharmaceuticals (BCRX) Provides Corporate Update and Reports First Quarter 2013 Financial Results
5/7/2013 8:07:10 AM
More...
|
Biocryst Pharmaceuticals (BCRX) to Announce First Quarter 2013 Financial Results May 7
4/23/2013 6:49:51 AM
More...
|
Biocryst Pharmaceuticals (BCRX) Completes Peramivir Type C Meeting
4/16/2013 11:06:37 AM
More...
|
Biocryst Pharmaceuticals (BCRX) Receives Preliminary Comment Letter From FDA on Peramivir
4/1/2013 6:33:34 AM
More...
|
Biocryst Pharmaceuticals (BCRX) Announces Initiation of a Phase 1 Clinical Trial of BCX4161 for the Treatment of Hereditary Angioedema
3/25/2013 9:34:52 AM
More...
|
Biocryst Pharmaceuticals (BCRX) Reports Fourth Quarter and Full Year 2012 Financial Results
2/19/2013 6:11:50 AM
More...
|
Biocryst Pharmaceuticals (BCRX) to Announce Fourth Quarter & 2012 Financial Results on February 19, 2013
2/5/2013 11:07:40 AM
More...
|
Biocryst Pharmaceuticals (BCRX) Sweetens Pot for Employees
1/8/2013 8:20:56 AM
More...
|
Biocryst Pharmaceuticals (BCRX) to Present at J.P. Morgan Healthcare Conference
1/3/2013 6:08:37 AM
More...
|
|